enVVeno Medical Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -2.9% | +5.2% | -3.5% | -5.1% | -5.4% | +0.0% | +6.6% | -7.7% | -2.5% | +6.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.5% | +2.4% | -7.4% | +1.2% | +22.9% | -27.2% | +13.1% | -10.6% | -24.6% | +8.4% | -1.7% | – | |
| – | +29.2% | -25.7% | +7.3% | +25.9% | -3.8% | -24.8% | +73.5% | -44.7% | -10.1% | -5.5% | -11.8% | – | |
| – | +17.9% | -12.7% | -0.8% | +13.6% | +8.9% | -26.5% | +43.2% | -31.2% | -18.2% | +4.3% | -6.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -93.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.